Pilot Study of Alteplase (Tissue Plasminogen Activator) for Treatment of Urinary Clot Retention in an <i>In Vitro</i> Model

Abstract

In this in vitro study, a single 25 mL instillation of t-PA solution 2 mg/mL is significantly better than sterile water alone for clot evacuation. In vivo animal studies are pending.